Loading clinical trials...
Loading clinical trials...
This single-center, open-label, randomized clinical trial evaluates the effect of 0.15% benzydamine hydrochloride (Difflam) oral spray on the severity of radiation-induced oral mucositis in patients w...
Bring this clarity to your next appointment.
Keep all your medical notes and next steps in one place.
Lead Sponsor
Tishreen University
NCT07282483 · Radiation-induced Oral Mucositis
NCT07040969 · Radiation-induced Oral Mucositis
NCT07538934 · Radiation-induced Oral Mucositis, Oral Malignancy
NCT07252557 · Head and Neck Cancer (H&Amp;Amp;N), Radiation-induced Oral Mucositis, and more
NCT04110977 · Radiation Dermatitis, Radiation-induced Oral Mucositis
Pharmacy, Latakia university
Latakia
Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.
Start free trial →Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions